Xenon Pharmaceuticals Inc. (XENE): Price and Financial Metrics

Xenon Pharmaceuticals Inc. (XENE)

Today's Latest Price: $13.38 USD

0.40 (-2.90%)

Updated May 27 4:00pm

Add XENE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

XENE Stock Summary

  • Of note is the ratio of Xenon Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; just 10.87% of US stocks have a lower such ratio.
  • With a price/sales ratio of 34.65, Xenon Pharmaceuticals Inc has a higher such ratio than 95.45% of stocks in our set.
  • Revenue growth over the past 12 months for Xenon Pharmaceuticals Inc comes in at 297.34%, a number that bests 97.79% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Xenon Pharmaceuticals Inc are UMRX, LQDA, MCRB, KALV, and CLDX.
  • XENE's SEC filings can be seen here. And to visit Xenon Pharmaceuticals Inc's official web site, go to www.xenon-pharma.com.
XENE Daily Price Range
XENE 52-Week Price Range

XENE Stock Price Chart More Charts

XENE Price/Volume Stats

Current price $13.38 52-week high $18.45
Prev. close $13.78 52-week low $7.00
Day low $12.50 Volume 149,200
Day high $13.86 Avg. volume 265,078
50-day MA $12.37 Dividend yield N/A
200-day MA $11.90 Market Cap 467.95M

Xenon Pharmaceuticals Inc. (XENE) Company Bio

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing differentiated therapeutics for orphan indications in Canada. The company was founded in 1996 and is based in Burnaby, Canada.

XENE Latest News Stream

Event/TimeNews Detail
Loading, please wait...

XENE Latest Social Stream

Loading social stream, please wait...

View Full XENE Social Stream

Latest XENE News From Around the Web

Below are the latest news stories about Xenon Pharmaceuticals Inc that investors may wish to consider to help them evaluate XENE as an investment opportunity.

Earnings Beat: Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) just released its latest quarterly results and things are looking bullish...

Yahoo | May 25, 2020

The Xenon Pharmaceuticals (NASDAQ:XENE) Share Price Is Up 247% And Shareholders Are Boasting About It

It hasn't been the best quarter for Xenon Pharmaceuticals Inc. (NASDAQ:XENE) shareholders, since the share price has...

Yahoo | May 22, 2020

Xenon Pharmaceuticals Inc (XENE) Q1 2020 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by and welcome to the Q1 2020, Xenon Pharmaceuticals Earnings Conference Call. Joining me on today's call are Dr. Simon Pimstone, Xenon's Chief Executive Officer; and Ian Mortimer, Xenon's President and Chief Financial Officer.

Yahoo | May 22, 2020

Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Misses Revenue Estimates

Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of 29.03% and -5.63%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research | May 21, 2020

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2020 Financial Results and Provide Corporate Update

BURNABY, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today…

GlobeNewswire | May 14, 2020

Read More 'XENE' Stories Here

XENE Price Returns

1-mo 0.45%
3-mo -7.21%
6-mo 13.10%
1-year 34.07%
3-year 234.50%
5-year -3.04%
YTD 2.06%
2019 107.77%
2018 123.36%
2017 -63.31%
2016 -4.23%
2015 -59.29%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0382 seconds.